Global diagnostics Genlantis Diagnostics specializes in rapid self-test kits for infectious viruses (HBV, HCV, HIV, Dengue, Chikungunya, Zika), presenting opportunities to partner with distributors and clinics in regions with high prevalence of these diseases to expand market reach.

Mid-market footprint With 11-50 employees and revenue in the 1M-10M range, there is potential to scale collaborations through channel partnerships, contract manufacturing, or OEM opportunities with larger medical device firms seeking niche infectious disease tests.

Digital engagement Existing tech stack including Open Graph, React, Framer Motion and DX Delivery Service suggests readiness for digital marketing, direct-to-consumer sales, and online training portals to reduce sales cycle and enhance customer onboarding.

Strategic expansion San Diego headquarters and focus on rapid self-tests align with growing demand for point-of-care diagnostics; explore partnerships with hospitals, urgent care networks, and travel clinics expanding infectious disease screening capabilities.

Competitive positioning Operate in a space with major players (QIAGEN, Thermo Fisher, Illumina, etc.). Opportunities exist to differentiate via bundled testing solutions, differentiated data capture, or targeted trials for regions with outbreaks to demonstrate value and capture lead share.